New vaccine technologies to combat outbreak situations
Ever since the development of the first vaccine more than 200 years ago, vaccinations have
greatly decreased the burden of infectious diseases worldwide, famously leading to the …
greatly decreased the burden of infectious diseases worldwide, famously leading to the …
Adenoviral vector-based vaccine platform for COVID-19: Current status
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …
21st century, claiming millions of lives and putting a huge burden on the global economy …
Nanocarrier vaccines for SARS-CoV-2
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death
associated with substantive social, economic and societal impacts. Treatments rely on re …
associated with substantive social, economic and societal impacts. Treatments rely on re …
Tunable and reversible drug control of protein production via a self-excising degron
HK Chung, CL Jacobs, Y Huo, J Yang… - Nature chemical …, 2015 - nature.com
An effective method for direct chemical control over the production of specific proteins would
be widely useful. We describe small molecule–assisted shutoff (SMASh), a technique in …
be widely useful. We describe small molecule–assisted shutoff (SMASh), a technique in …
An overview of nanocarrier-based adjuvants for vaccine delivery
KC Petkar, SM Patil, SS Chavhan, K Kaneko… - Pharmaceutics, 2021 - mdpi.com
The development of vaccines is one of the most significant medical accomplishments which
has helped to eradicate a large number of diseases. It has undergone an evolutionary …
has helped to eradicate a large number of diseases. It has undergone an evolutionary …
Novel viral vectors in infectious diseases
IR Humphreys, S Sebastian - Immunology, 2018 - Wiley Online Library
Since the development of vaccinia virus as a vaccine vector in 1984, the utility of numerous
viruses in vaccination strategies has been explored. In recent years, key improvements to …
viruses in vaccination strategies has been explored. In recent years, key improvements to …
Replicating and non-replicating viral vectors for vaccine development
M Robert-Guroff - Current opinion in biotechnology, 2007 - Elsevier
Viral vectors provide a convenient means to deliver vaccine antigens to select target cells or
tissues. A broad spectrum of replicating and non-replicating vectors is available. An …
tissues. A broad spectrum of replicating and non-replicating vectors is available. An …
Review of dengue virus and the development of a vaccine
Dengue viral infection has become an increasing global health concern with over two-fifths
of the world's population at risk of infection. It is the most rapidly spreading vector borne …
of the world's population at risk of infection. It is the most rapidly spreading vector borne …
Multivalent and multipathogen viral vector vaccines
KB Lauer, R Borrow, TJ Blanchard - Clinical and Vaccine …, 2017 - Am Soc Microbiol
The presentation and delivery of antigens are crucial for inducing immunity and, desirably,
lifelong protection. Recombinant viral vectors—proven safe and successful in veterinary …
lifelong protection. Recombinant viral vectors—proven safe and successful in veterinary …
A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus
S Brandler, C Ruffié, C Combredet, JB Brault… - Vaccine, 2013 - Elsevier
Chikungunya virus (CHIKV), a mosquito-transmitted alphavirus, recently reemerged in the
Indian Ocean, India and Southeast Asia, causing millions of cases of severe polyarthralgia …
Indian Ocean, India and Southeast Asia, causing millions of cases of severe polyarthralgia …